Website Changes
04/03/2024
Tumor Takedown Fundraiser: Cape Coral, FL May 4, 2024
04/01/2024
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide
04/01/2024
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
03/30/2024
Low-Grade Glioma Webinar TOMORROW
03/29/2024
Prolonged use of certain hormone drugs linked to increased brain tumor risk
03/29/2024
Advocacy Alert for Washington Residents! Comment publicly to support Washington State HCA coverage of Tumor Treating Fields
03/28/2024
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
03/28/2024
First Participant Receives Sonodynamic Therapy for Glioblastoma in New Clinical Trial
03/25/2024
Oncovir Inc. is Pushing the Boundaries of Medical Innovation with Hiltonol
03/25/2024
Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta
03/25/2024
Bill would allow treatment for terminally ill before FDA approval
03/18/2024
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma
03/18/2024
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database
03/18/2024
Hoops For Hannah: , a March Madness bracket contest!
03/17/2024
Musella Foundation Copay Program now closed to new and renewal patients
03/14/2024
Early clinical trial results show `dramatic and rapid` regression of glioblastoma after next generation CAR-T therapy
03/14/2024
Gallium maltolate webinar added to website!
03/12/2024
Rod Norland`s book receives praise from brain tumor community
03/12/2024
Musella Foundation Copay Program Almost Closed!
03/10/2024
We’re having a webinar this Wednesday, March 13 at 7pm EST (6pm CST) on Gallium Maltolate!
03/10/2024
International war correspondent reflects on glioblastoma diagnosis in his memoir
03/10/2024
Tumor-Treating Fields Dosimetry in Glioblastoma: Insights into Treatment Planning, Optimization, and Dose-Response Relationships
03/10/2024
Phase 1 Car T cell trial shows promising results in high grade glioma
03/10/2024
New NIH Phase 1/2 clinical trial on Zotiraciclib for recurrent IDH-mutant gliomas
03/09/2024
Berberine as a potential enhancer for 5-ALA-mediated fluorescence in glioblastoma: increasing detectability of infiltrating glioma stem cells to optimize 5-ALA-guided surgery
which delivers brain tumor news and additions
to the website via RSS.